Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000988331 | SCV004102781 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency | 2023-11-14 | reviewed by expert panel | curation | The NM_001033855.3:c.512C>G variant in DCLRE1C is a missense variant predicted to cause the substitution of proline by arginine at amino acid 171 (p.Pro171Arg). This variant has an allele frequency of 0.19422 in the East Asian population in gnomAD, which is above the threshold for BA1 set by the ClinGen SCID VCEP for DCLRE1C (>0.00346). In addition, this variant is present 1394 adult homozygous individuals in gnomADv2.1.1 (distributed in all gnomAD populations)(BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG criteria applied: BA1 and BS2_Supporting, as specified by the ClinGen SCID VCEP (VCEP specifications version 1). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029657 | SCV000052309 | benign | Severe combined immunodeficiency disease | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Benign. |
Prevention |
RCV000244893 | SCV000305989 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000305875 | SCV000361560 | benign | Histiocytic medullary reticulosis | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV001650846 | SCV000603291 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988331 | SCV001138003 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000988331 | SCV001720361 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000988331 | SCV001750448 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001650846 | SCV001863142 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25917813, 21664875, 23701501, 20674517) |
Fulgent Genetics, |
RCV002496450 | SCV002813063 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency; Histiocytic medullary reticulosis | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000305875 | SCV001455087 | benign | Histiocytic medullary reticulosis | 2020-09-16 | no assertion criteria provided | clinical testing |